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Abstract. Brazilian agribusiness became increasingly competitive on the global agribusiness stage 
primarily in the animal production. In the first quarter of 2011 were slaughtered 8.160 million of pigs and 
1.306 billion of chickens. To ensure the productivity and competitiveness of the sector, the use of drugs as 
growth promoters is a common practice. However, the use of substances as antimicrobial growth 
promoters has been discussed and is subject to a series of rules because the literature has been reporting 
the presence of bacteria resistant. The concern about the growth of bacterial resistance to antibiotics has 
stimulated the search for alternatives that will replace these substances as growth promoters. The aim of 
this study was to evaluate the antibiotic sensibility of Listeria innocua (CECT 910) and Listeria 
monocytogenes (CECT 4032) in the presence of natural antimicrobial agents. The DMSO was used as 
dilution agent for obtaining the levels of 0.100 and 0.175 µL/mL for carvacrol and levels of 0.150 and 0.250 
µL/mL for citral. Assessing the strains of L. monocytogenes and L. innocua, it was verified that the 
sensibility to erythromycin was of the 0.250 µg/mL. There was reduction of the minimal inibitory 
concentration (MIC) of erythromycin in the presence of antimicrobials carvacrol or citral in cultures of L. 
innocua and L. monocytogenes to 0.094-0.125 µg/mL. In this study the MIC of bacitracin in cultures of L. 
innocua and L. monocytogenes was of 32 μg/mL. However, there was reduction of MIC in the presence of 
antimicrobials carvacrol or citral. The MIC of colistin in cultures of L. innocua and L. monocytogenes was 
reduced in the presence of antimicrobial carvacrol or of citral from 96-128 μg/mL to 4 μg/mL. The results 
obtained in this study showed that the combined use of antibiotics with natural antimicrobial resulted in a 
synergistic effect demonstrated by the reduction of the MIC in cultured of L. monocytogenes and L. 
innocua.  
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Introduction 
Brazilian agribusiness became increasingly competitive on the global agribusiness 
stage primarily in the animal production. In the first quarter of 2011 were slaughtered 
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8.160 million of pigs and 1.306 billion of chickens (IBGE, 2011). To ensure the 
productivity and competitiveness of the sector, the use of drugs as growth promoters is 
a common practice (Regitano & Leal, 2010) that has been adopted since the 50s 
(Pelicano, et al., 2004, Rocha et al., 2010). However, the use of substances as 
antimicrobial growth promoters has been discussed and is subject to a series of rules 
because the literature has been reporting the presence of bacteria resistant to 
antimicrobial agents by the widespread use of antibiotics in the treatment and 
prevention of infectious diseases in humans and animals and also the use of antibiotics 
in animal production (Turnidge, 2004). Some of these antibiotics used in animals are 
similar to application in humans, which can result in cross-resistance (WHO, 1997, 
WHO, 2004; BRAZIL, 2004; Regitano & Leal, 2010). 
Since 1986, Sweden abolished the use of any antibiotic as growth promoter. Denmark 
did the same for avoparcin and virginamicin since 1995 and joined the European Union 
in 1997 for avoparcin and later to four other classes of antibiotics: bacitracin, 
spiramycin, tylosin and virginamicin (Boerlin et al., 2001; Casewell et al., 2003). In the 
year 2013 all countries of the European community will no longer use antibiotics as 
growth promoters, restricting the use only for therapeutic purposes (EC, 2003). 
In 2000, the Ministry of Agriculture, Livestock and Supply of Brazil (MAPA) institiuted a 
Technical Group should review and reassess the use of substances carbadox, 
olaquindox, bacitracin zinc, spiramycin, virginiamycin and tylosin phosphate as 
additives in animal feed (BRAZIL, 2003; Spisso, Nóbrega & Marques, 2009). The 
concern with the growth of bacterial resistance to antibiotics has stimulated the search 
for alternatives that will replace these substances as growth promoters (Freitas et al., 
2001, Rocha et al., 2010).  
 
Material and methods  
Listeria innocua (CECT 910) and Listeria monocytogenes (CECT 4032) strains were 
provided by the Spanish Type Culture Collection. The carvacrol and citral was 
purchased from Sigma Aldrich. The DMSO was used as dilution agent for obtaining the 
levels of 0.100 and 0.175 µL/mL for carvacrol and levels of 0.150 and 0.250 µL/mL for 
citral.  
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It was used Etest® (Biomerieux) that allows the quantitative determination of the 
minimal inibitory concentration (MIC) of antibiotic agents. Etest® consist of a plastic 
strip with a gradient of concentrations of the antibiotic.  
0.1 mL of an inoculum size approximately of 1-2x108 CFU/mL (CLSI, 2010) were pour-
plated onto Tryptone Soya Agar (TSA) that was supplemented with 0.6% of yeast 
extract (TSA-YE). It was added antimicrobial agents (carvacrol and citral) when the 
agar TSA-YE was in a liquid stated about at 45 °C. It was put on the plastic strips of 
antibiotics after the agar solidification. The sterile plastic petri plates were incubated 
upside down at 37 °C for 48 hours.  
Thus, L. innocua and L. monocytogenes were exposed to antimicrobial agents just in 
the moment of spreading. There was no prior exposure of carvacrol and citral to these 
bacterial strains. The list of the tested antibiotics and their concentration ranges are 
listed in Table 1. 
Table 1. List of antibiotics tested and their concentrations (µL/mL) by Etest ® 
(Biomerieux). 
Antibiotics Range of concentration (µg/mL) 
Bacitracin 0.016-256 
Eritromicin 0.016-256 
Colistin 0.016-256 
 
Results and discussion 
The Gram-positive bacteria are target for antibiotic growth promoters. Records showing 
the sensibility of Listeria spp. by the use of antibiotics combined with natural 
antimicrobials are inexistent, although there are reports with others bacteria as also 
there are studies that show the action of natural antimicrobials on gram positive 
bacteria.  
Assessing the strains of L. monocytogenes and L. innocua, it was verified that the 
sensibility to erythromycin was of the 0.250 µg/mL. (Table 2 and 3) which supports the 
reports of breakpoints recommended by the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST, 2012) which exhibit sensibility values ≤ 1 mg/L.  
There was reduction of the erythromycin MIC in the presence of antimicrobials 
carvacrol or citral in cultures of L. innocua and L. monocytogenes to 0.094-0.125 µg/mL 
(Tables 2 and 3). The carvacrol is composed of two molecules of isoprene being 
classified in the group of monoterpenes. Citral is a terpenoid that is oxygenated 
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derivative of terpenes, which is compound of a mixture of two isomers. The trans-
isomer is known as geranial or citral A. The cis-isomer is known as neral or citral B. 
Terpenes can be used as absorption enhancers for drugs due to their low toxicity and 
ability to increase permeability of both hydrophilic and lipophilic molecules (El-Kattan, 
Asbill & Michniak, 2000). It was know the limitation of drugs for the passage into the 
biological membrane and cell wall. The effect of terpenes can be attributed to its ability 
to affect the packing of intercellular lipid.  
Erythromycin is an analogue of tylosin (Klare et al., 2003), which is used as an 
antibiotic growth promoter approved by the MAPA (BRAZIL, 2009). The intensive use 
of this promoter can result in selective pressure on the resistance genes. In human 
medicine macrolides have therapeutic application frequent and serve as second choice 
in cases of allergy to other antimicrobial agents (Jensen, Frimodt-Moller, Aarestrup, 
1999). It is well documented macrolide resistance of isolated from humans and animals 
(Aarestrup et al., 2000; Aarestrup et al., 2001). The bacteria may have intrinsic 
mechanisms of resistance by low permeability to antibiotics, common to Gram-negative 
bacteria and acquired by the change of target in the ribosome binding (Fluit, Visser & 
Schmitz, 2001), the presence of efflux pump (Luna et al., 1999) and degradation of the 
antibiotic (Leclerq & Courvalin, 1991; Leclercq et al., 1991), common to Gram-positive 
bacteria.  
According to Clinical and Laboratory Standards Institute (CLSI, 2010), the Listeria 
monocytogenes is susceptible to penicillin, ampicillin and gentamicins and intrinsically 
resistant to cephalosporins.  
In this study the bacitracin MIC in cultures of L. innocua and L. monocytogenes was of 
32μg/mL. However, there was reduction of MIC in the presence of antimicrobials 
carvacrol or citral (Tables 2 and 3). No breakpoint values for L. monocytogenes and L. 
innocua with regard to bacitracin. However, according to EUCAST (2012) there are 
three categories of bacteria sensibility to antibiotics as sensible (= <1 mg/L), 
intermediate (> 1-8 mg/L) and resistant (> 8 mg/L). Bacitracin is an antibiotic produced 
by strains of Bacillus licheniformis, and is a more stable as the zinc salt being used as 
animal growth promoter and therapeutically, in topical application on human and 
veterinary medicine. Bacitracin has the mode of action based on inhibition of bacterial 
cell wall synthesis. This antibiotic is particularly active on gram-positive bacteria 
(O'Grady & Greenwood, 1997). It can be used orally and also topically in humans 
(Bywater et al., 2005; Pavli & Kmetec, 2006).  
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The MIC of colistin was of 96-128 mg/ml (Tables 2 and 3) for L. monocytogenes and L. 
innocua, respectively, indicating resistance to this antibiotic. This resistance occurs 
because the colistin is an antibiotic for Gram-negative bacteria and do not show activity 
on gram-positive bacteria. The colistin is produced by B. colistinus, also called 
polymyxin E. It is a bactericidal that interacts with phospholipids and 
lipopolysaccharides of the cell wall of Gram-negative bacteria and it`s promotes 
alterations in this structure and the cytoplasmic membrane (Machado Sequeira, 2004). 
However, the colistin MIC in cultures of L. innocua and L. monocytogenes was reduced 
in the presence of antimicrobial carvacrol or of citral from 96-128μg/mL to 4μg/mL 
(Tables 2 and 3) Therefore, L. innocua and L. monocytogenes become sensitive to this 
antibiotic.  
In this study also evaluated the combined effect of these antimicrobial agents (citral 
and carvacrol) and it was observed promising results for the MIC of bacitracin, 
erythromycin and colistin that was reduced to 0.25-1.0, 0.064 and 0.75 µg/mL, 
respectively (Tables 2 and 3). The antimicrobial compounds may interact enhancing its 
activity or reducing it. There are identified three types of interactions between them: 
addition that occurs when the activity of the mixture of antimicrobial compounds is the 
sum of individual effects, antagonism that occurs when the activity is less than the sum 
of the antimicrobial activity individually; synergy that occurs when the compound 
mixture is greater than the sum of their individual effects (Burt, 2004).  
The antimicrobial activity of compounds extracted from plants is directly related to 
chemical structure, its proportion and interaction that can occur between them (Burt, 
2004). Some authors have described additive effects, synergistic or antagonistic 
combinations between components such as carvacrol and thymol, p-cymene and 
carvacrol, cinnamaldehyde and eugenol (Burt, 2004; Tajkarimi et al., 2010). The 
combined use of antibiotics is one strategy that is used to treat infections caused by 
resistant or multiresistant strains to antibiotics and decreases the occurrence of new 
mechanisms of resistance (Hemaiswarya et al., 2008). Some studies have shown that 
mixture the essential oils and their individual components have synergistic effects with 
antibiotics. For example, has been described that the essential oil of Pelargonium 
graveolens increases the activity of norfloxacin on B. cereus and S. aureus (Rosato et 
al., 2007), as also cinnamaldehyde and clindamycin have synergistic effects against 
Clostridium difficile (Shahverdi et al., 2007) and that the essential oil of Zataria 
multiflora improved the vancomycin activity on S. aureus (Mahboubi & Ghazian Bidgoli, 
2010).  
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Table 2. Minimum inhibitory concentration of antibiotics in the presence or not of natural antimicrobial (carvacrol and/or citral) in complete 1 
culture medium (TSA-YE) for L. innocua. 2 
 Listeria innocua 
 Minimum inhibitory concentration 
    
Carvacrol (µL/mL) Citral (µL/mL) Anitmicrobials mix (µL/mL) 
0.100 0.175 0.150 0.250 0.100 x 0.150 0.100 x 0.250 
          
Bacitracin (µg/mL) 32.0   4.0 1.5-2.0 24.0 12.0 2.0 0.25-1.0 
Erythromycin (µg/mL)  0.250  0.125 0.094-0.125 0.190-0.250 0.250 0.064 0.064 
Colistina (µg/mL)   128.0 16.0 4.0 16.0 4.0 1.5 0.75 
 3 
 4 
 5 
Table 3. Minimum inhibitory concentration of antibiotics in the presence or not of natural antimicrobial (carvacrol and/or citral) in complete 6 
culture medium (TSA-YE) for L. monocytogenes. 7 
 Listeria monocytogenes 
 Minimum inhibitory concentration 
    Carvacrol (µL/mL) Citral (µL/mL) Anitmicrobials mix (µL/mL) 
0.100 0.175 0.150 0.250 0.100 x 0.150 0.100 x 0.250 
          
Bacitracina (µg/mL) 32.0   4.0 1.5-2.0 24.0 12.0 2.0 0.250 
Erythromycin (µg/mL)  0.250  0.125 0.094-0.125 0.250 0.250 0.094 0.016 
Colistina (µg/mL)   96.0 24.0 4.0 16.0 4.0 2.0-3.0 2.0 
 8 
 9 
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Conclusions 
The results obtained in this study showed that the combined use of antibiotics with 
natural antimicrobial resulted in a synergistic effect demonstrated by the reduction of 
the MIC in cultured of L. monocytogenes and L. innocua.  
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